Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cetuximab, capecitabine and irinotecan with radiotherapy before surgery for cancer of the rectum (EXCITE)

Overview

Cancer types:

Bowel (colorectal) cancer, Rectal cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at cetuximab, capecitabine and irinotecan with radiotherapy before surgery for rectal cancer that has spread into the surrounding tissues. It was supported by Cancer Research UK.

Recruitment start: 9 April 2009

Recruitment end: 24 October 2011

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Simon Gollins

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

University College London (UCL)

Other information

This is Cancer Research UK trial number CRUK/07/043.

Last reviewed: 11 January 2018

CRUK internal database number: 2129

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.